T42.2X3
Poisoning by succinimides and oxazolidinediones, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T42.2X3 refers to poisoning caused by succinimides and oxazolidinediones as a result of assault. Succinimides and oxazolidinediones are classes of medications mainly used to treat neurological conditions such as epilepsy and certain bacterial infections. Poisoning with these drugs can occur intentionally or accidentally, with assault representing a deliberate act of harm.
Causes & Symptoms
Clinical Causes: Intentional overdose or poisoning during assault or abuse Accidental ingestion due to mislabeling or improper storage Combination with other toxic substances leading to enhanced effects Misuse by individuals seeking recreational effects
Key Symptoms: Nausea and vomiting Dizziness or lightheadedness Drowsiness or sedation Loss of coordination Confusion or altered mental state Respiratory depression in severe cases Seizures or convulsions if toxicity is significant Cardiovascular symptoms such as irregular heartbeat
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough clinical assessment, including a detailed history of recent medication intake or exposure. Laboratory tests such as blood and urine toxicology screens can detect the presence of succinimides and oxazolidinediones. Additional investigations like electrocardiograms (ECG) may be performed if cardiac symptoms are present. Healthcare providers also evaluate vital signs and neurological status to determine the severity of poisoning.
Treatment Protocols: Management of poisoning by succinimides and oxazolidinediones involves supportive care and specific interventions. These may include:
Clinical Advice & FAQs
Billing Guidance
Is T42.2X3 a billable ICD-10 code?
Yes, T42.2X3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T42.2X3?
Clinical documentation must specify the nature of Poisoning by succinimides and oxazolidinediones, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference